Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aptorum Group Ltd Cl A
(NQ:
APM
)
2.990
+0.110 (+3.82%)
Streaming Delayed Price
Updated: 1:50 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptorum Group Ltd Cl A
< Previous
1
2
3
4
5
6
7
Next >
Aptorum's Shares Jump After ALS-4 Targeting Staphylococcus Aureus Shows Encouraging Action In Early-Stage Study
May 24, 2021
Aptorum Group Limited (NASDAQ: APM) has completed two initial cohorts of the single-dose ascending dose (SAD) portion of the Phase 1 trial evaluating ALS-4...
Via
Benzinga
Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
May 24, 2021
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited to Present at The Benzinga Global Small Cap Conference
May 13, 2021
From
Aptorum Group Limited
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 10, 2021
Gainers Conformis (NASDAQ:CFMS) stock moved upwards by 29.53% to $1.09 during Monday's pre-market session. The company's market cap stands at $198.8 million. As...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum’s Novel Preclinical Candidate Targeting Woman’s Gynecological Conditions
May 06, 2021
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Interview to Air on Bloomberg Television U.S. on the RedChip Money Report
April 23, 2021
From
Aptorum Group Limited
Via
Business Wire
Aptorum Shares Are Trading Higher On Immunomodulators Agreement For Autoimmune, Oncology Indications
April 22, 2021
Aptorum Group Ltd (NASDAQ: APM) has entered into a material transfer and option agreement with Yale University to evaluate a group of preclinical stage novel...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 22, 2021
Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
April 22, 2021
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Reports 2020 Fiscal Year End Financial Results and Provides Business Update
April 19, 2021
From
Aptorum Group Limited
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.